SESSION 1 | 13:05 – 13:40
Nonneovascular AMD and IRDs
Moderators: Kourous Rezaei / Frank Holz
13:05
Cedric Francois, Apellis — Committed to Saving Retina and Preserving Function in GA
13:10
Sharon Bakalash, Astellas — Revealing the Master Key: Unlocking Success in the treatment of Geographic Atrophy
13:15
Tarek Hassan, Aviceda — Glycoimmunology in the Management of Geographic Atrophy from AMD
13:20
David Zacks, ONL Therapeutics — Targeting Fas Pathway: ONL Therapeutics’ Approach to Dry AMD
13:25
Doug Love, Annexon Biosciences — Preservation of Vision by ANX007 in Geographic Atrophy: Clinical Results and Anatomical Changes from the Phase 2 ARCHER Trial
13:30
Panel Discussion — Kourous Rezaei, Frank Holz, Cedric Francois, Sharon Bakalash, Tarek Hassan & David Zacks
